CN113440438A - Multi-effect antioxidant fine night cream and preparation method thereof - Google Patents
Multi-effect antioxidant fine night cream and preparation method thereof Download PDFInfo
- Publication number
- CN113440438A CN113440438A CN202110624908.XA CN202110624908A CN113440438A CN 113440438 A CN113440438 A CN 113440438A CN 202110624908 A CN202110624908 A CN 202110624908A CN 113440438 A CN113440438 A CN 113440438A
- Authority
- CN
- China
- Prior art keywords
- extract
- night cream
- water
- skin
- night
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 57
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 81
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 17
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 16
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 claims abstract description 16
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 16
- 241000907663 Siproeta stelenes Species 0.000 claims abstract description 16
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 claims abstract description 16
- 229960003237 betaine Drugs 0.000 claims abstract description 16
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 claims abstract description 16
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 16
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 15
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 15
- -1 biogum-1 Chemical compound 0.000 claims abstract description 13
- VUAHCCXOHUUNOR-UHFFFAOYSA-N 2-(3-hydroxypropyl)oxolane-2,3,4-triol Chemical compound C1C(C(C(O1)(CCCO)O)O)O VUAHCCXOHUUNOR-UHFFFAOYSA-N 0.000 claims abstract description 11
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims abstract description 9
- 108010087806 Carnosine Proteins 0.000 claims abstract description 9
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims abstract description 9
- 244000272459 Silybum marianum Species 0.000 claims abstract description 9
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 9
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims abstract description 9
- 229940044199 carnosine Drugs 0.000 claims abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 9
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 8
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 8
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims description 35
- 239000000126 substance Substances 0.000 claims description 28
- 238000001816 cooling Methods 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 16
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 15
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 15
- 235000006708 antioxidants Nutrition 0.000 claims description 15
- 235000021283 resveratrol Nutrition 0.000 claims description 15
- 229940016667 resveratrol Drugs 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 241000242583 Scyphozoa Species 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 8
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 7
- 241001071917 Lithospermum Species 0.000 claims description 7
- 230000000035 biogenic effect Effects 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 7
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 7
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- 229960001295 tocopherol Drugs 0.000 claims description 7
- 229930003799 tocopherol Natural products 0.000 claims description 7
- 235000010384 tocopherol Nutrition 0.000 claims description 7
- 239000011732 tocopherol Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- 229940084062 lilium candidum flower extract Drugs 0.000 claims description 6
- 229940069826 chlorella vulgaris extract Drugs 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- JFSQSDAOQLNSQI-DTBJPNGVSA-N 2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-(hexadecanoylamino)-3-methylbutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O JFSQSDAOQLNSQI-DTBJPNGVSA-N 0.000 claims description 2
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 2
- 229940099417 ceramide 2 Drugs 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 229940077272 palmitoyl hexapeptide-12 Drugs 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 claims 1
- 229940106025 phenylethyl resorcinol Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 230000014759 maintenance of location Effects 0.000 abstract description 6
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 abstract description 5
- 241000207929 Scutellaria Species 0.000 abstract description 3
- 239000002932 luster Substances 0.000 abstract description 3
- 240000008058 Lilium brownii Species 0.000 abstract description 2
- 235000015982 Lilium brownii Nutrition 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- VNXWANZMRATDQM-UHFFFAOYSA-N 2-(2-phenylethyl)benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CCC1=CC=CC=C1 VNXWANZMRATDQM-UHFFFAOYSA-N 0.000 description 6
- 241000195950 Equisetum arvense Species 0.000 description 6
- 239000005768 Equisetum arvense L. Substances 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 5
- 229940106189 ceramide Drugs 0.000 description 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 5
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 240000004534 Scutellaria baicalensis Species 0.000 description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 3
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000272503 Sparassis radicata Species 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 241001313857 Bletilla striata Species 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000272534 Struthio camelus Species 0.000 description 1
- 241001521901 Tribulus lanuginosus Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000008667 sleep stage Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a multi-effect antioxidant fine night cream and a preparation method thereof, and the night cream contains jojoba oil, hydroxypropyl tetrahydrofuran triol, betaine, biogum-1, platinum powder, tocopherol succinate, malachite extract, ascorbyl tetraisopalmitate, aspartic acid, carnosine, scutellaria root extract, silybum marianum fruit extract, hypecol extract, avenin, lilium brownii flower extract, tranexamic acid and the balance of water. The multi-effect antioxidant fine night cream provided by the invention has better skin feel, moisture retention, spreadability and stability, can moisten skin cuticle at night, enables the skin to be sufficiently maintained, enables the skin to be moist and beautiful, and simultaneously keeps the effects of fineness, cleanness, smoothness, luster, water supplement, moisture retention, fineness and smoothness.
Description
Technical Field
The invention relates to the field of daily skin care products, in particular to a multi-effect antioxidant night cream and a preparation method thereof.
Background
Skin oxidation is a phenomenon that cell apoptosis, organ tissue mutation, skin aging, immunity decrease and the like are caused by excessive free radicals on skin. The important characteristics of the oxidized skin are that the color of the face turns yellow, spots and flaws are increased, the luster is lost, and the beauty is influenced. These oxidative free radicals also cause collagen hydrolysis, relaxation and fragility of elastic fibers, and slow epidermal neogenesis.
Our living social environment contains a number of causes of excessive oxidation including air pollution, electromagnetic radiation, high-sugar, high-lipid diets and significant mental stress. More and more studies show that anti-oxidation is a key step in anti-aging. Therefore, the skin degeneration speed needs to be delayed and the youth is kept through the antioxidant. Night cream is a skin care product for continuously repairing skin in the sleep stage of people, and is the most important step of basic skin care.
The night cream in the current market has unsatisfactory effect and certain defects in efficacy, skin feel and cost. For example, the invention patent with the publication number of CN111150682A discloses an Sparassis crispa antioxidant whitening cream which comprises whitening powder, vitamins, ostrich oil, Sparassis crispa extract, hyaluronic acid and licoflavone, wherein the whitening powder comprises one or more of cortex mori radicis, radix ampelopsis, rhizoma atractylodis macrocephalae, angelica sinensis, tribulus terrestris, bletilla striata, poria cocos, radix paeoniae alba and perilla frutescens. The cream has good whitening effect, but weak antioxidant function.
Disclosure of Invention
The purpose of the invention is as follows: aiming at the defects of the prior art, the invention aims to provide the multi-effect antioxidant fine night cream which has the effects of resisting aging, keeping the skin fine, clean, smooth and glossy, replenishing water and moisturizing, and is fine and smooth.
The technical scheme of the invention is as follows:
in order to achieve the purpose, the invention provides a multi-effect antioxidant fine night cream, which comprises the following components in percentage by weight: 5-15% of jojoba oil, 5-30% of hydroxypropyl tetrahydrofuran triol, 1-8% of betaine, 15-15% of bioglycan gum, 1-5% of resveratrol, 0.1-2% of platinum powder, 0.1-2% of tocopherol succinate, 0.1-2% of malachite extract, 0.1-2% of ascorbyl tetraisopalmitate, 0.5-5% of aspartic acid, 0.1-2% of carnosine, 0.2-2% of radix scutellariae extract, 0.1-2% of silybum marianum fruit extract, 0.1-2% of hypecol extract, 0.02-0.8% of oat peptide, 1-2% of lilium candidum flower extract, 0.01-0.5% of tranexamic acid and the balance of water.
The jojoba oil disclosed by the invention contains abundant vitamin D, has good moistening and moisturizing effects, can lock water, and prevents wrinkles; meanwhile, the skin care oil is used as a good oil phase cosolvent, and can assist other components in night cream to penetrate through skin barriers, so that the effect of nourishing the skin is achieved; in addition, the detergent can clean pore dirt and improve inflammation.
In addition, the jojoba oil and the hydroxypropyl tetrahydrofuran triol can improve the water-oil balance of skin at night, and can promote the emulsification and mutual solubility of other components in the night cream, so that the skin feel and the spreadability of the prepared night cream are obviously improved.
The biological sugar gum-1, the betaine and the lilium brownii extract can improve the moisturizing effect of night cream and play a role in diminishing inflammation and relieving.
The platinum powder, the tocopherol succinate, the resveratrol, the malachite extract, the ascorbyl tetraisopalmitate, the scutellaria root extract, the silybum marianum fruit extract, the hypecol extract and the like can effectively prevent active oxygen free radicals generated by UV and electromagnetic radiation, thereby effectively enhancing the skin vitality and contacting with the skin fatigue.
The carnosine and the oat peptide can inhibit the activity of metal matrix protease, link the lapse of collagen, and promote the metabolism of skin newcastle, thereby enhancing the skin elasticity.
In order to prevent acne and adjust the pH value of the night cream, the night cream can also contain 0.01-0.05% of dipotassium glycyrrhizinate.
In order to further promote the water-oil balance, the night cream of the invention can also contain 0.1-2% of isobutyl palmitate.
In order to improve the whitening effect of the night cream, the night cream disclosed by the invention can also contain 0.1-3% of phenethyl resorcinol.
In order to improve the skin repairing function of the night cream, the night cream can also contain 0.01-0.5% of palmitoyl hexapeptide-12, 0.01-0.5% of ceramide 2, 0.1-3% of tyrosine and 0.1-3% of tocopherol.
In order to further improve the water locking and moisturizing functions of the night cream, the night cream disclosed by the invention can also contain 0.01-2% of jellyfish extract.
Further, the preparation method of the jellyfish extract comprises the following steps: cleaning fresh jellyfish with clear water, cleaning with 1-2 times volume of soda water, cutting, adding 4-6 times volume of mixed solvent composed of anhydrous ethanol and n-hexane at a volume ratio of 8-10:1, heating to reflux, extracting for 3-6 hr, cooling, filtering, and concentrating the filtrate to obtain jellyfish extract.
In order to further improve the effects of brightening the skin and whitening and repairing the skin of the night cream, the night cream can also contain 0.01-3% of an Equisetum arvense extract, 0.01-0.2% of a chlorella extract and 0.01-0.5% of a lithospermum extract.
The invention also provides a preparation method of the night cream, which specifically comprises the following steps:
s1, weighing the components according to the weight percentage, adding hydroxypropyl tetrahydrofuran triol, betaine, biogenic acid-1, tranexamic acid and water into a water phase reaction pot, uniformly mixing, heating to 80-90 ℃, stirring until the components are completely dissolved to obtain a water phase substance, and keeping the temperature for later use;
s2, adding jojoba oil, tocopherol succinate, resveratrol, ascorbyl tetraisopalmitate and radix scutellariae extract into an oil phase reaction pot, mixing uniformly, heating to 80-85 ℃, stirring until completely dissolved to obtain an oil phase substance, and keeping the temperature for later use;
s3, transferring the water phase substance prepared in the step S1 into an emulsifying pot, slowly adding the oil phase substance prepared in the step S2 while stirring, continuously stirring for 30-60 minutes, then adding platinum powder and malachite extracts, uniformly dispersing, and cooling to 40-50 ℃;
s4, adding other materials into the mixture prepared in the step S3, continuously stirring for 30-60 minutes, and cooling to room temperature to obtain the material.
Has the advantages that:
the multi-effect antioxidant fine night cream provided by the invention has better skin feel, moisture retention, spreadability and stability, can moisten skin cuticle at night, enables the skin to be sufficiently maintained, enables the skin to be moist and beautiful, and simultaneously keeps the effects of fineness, cleanness, smoothness, luster, water supplement, moisture retention, fineness and smoothness.
Detailed Description
The invention will be illustrated below with reference to specific embodiments. It should be noted that the following examples are illustrative of the present invention, and are not intended to limit the present invention. Other combinations and various modifications within the spirit or scope of the present invention may be made without departing from the spirit or scope of the present invention.
The contents referred to in the present invention are all contents by mass percent unless otherwise specified.
The manufacturers of some raw materials in night cream in the embodiment of the invention are as follows in table 1:
TABLE 1
Example 1
A multi-effect antioxidant fine night cream comprises the following components in percentage by weight: 10% of jojoba oil, 15% of hydroxypropyl tetrahydrofuryl triol, 5% of betaine, 110% of bioglycan gum, 1% of platinum powder, 1% of tocopherol succinate, 1% of malachite extract, 1% of ascorbyl tetraisopalmitate, 2% of aspartic acid, 0.5% of carnosine, 1% of scutellaria baicalensis root extract, 2% of phenethyl resorcinol, 0.8% of silybum marianum fruit extract, 0.5% of hypecol extract, 0.6% of avenin, 1% of lilium candidum flower extract, 1% of resveratrol, 1% of palmitoyl hexapeptide-121%, 20.1% of ceramide, 1% of equisetum arvense extract, 0.5% of tranexamic acid, 0.05% of dipotassium glycyrrhizinate, 0.1% of chlorella vulgaris extract, 0.5% of lithospermum extract, 1% of leucine, 0.5% of jellyfish extract, 3% of tocopherol, and the balance of water.
The night cream of this example was prepared as follows:
s1, weighing the components according to the weight percentage, adding hydroxypropyl tetrahydrofuran triol, betaine, biogenic acid-1, tranexamic acid and water into a water phase reaction pot, uniformly mixing, heating to 90 ℃, stirring until the components are completely dissolved to obtain a water phase substance, and keeping the temperature for later use;
s2, adding jojoba oil, tocopherol succinate, resveratrol, ascorbyl tetraisopalmitate and radix scutellariae extract into an oil phase reaction pot, uniformly mixing, heating to 80 ℃, stirring until the components are completely dissolved to obtain an oil phase substance, and keeping the temperature for later use;
s3, transferring the water phase substance prepared in the step S1 into an emulsifying pot, slowly adding the oil phase substance prepared in the step S2 while stirring, continuously stirring for 60 minutes, then adding platinum powder and malachite extracts, dispersing uniformly, and cooling to 50 ℃;
s4, adding other materials into the mixture prepared in the step S3, continuously stirring for 30 minutes, and cooling to room temperature to obtain the material.
Example 2
A multi-effect antioxidant fine night cream comprises the following components in percentage by weight: 15% of jojoba oil, 20% of hydroxypropyl tetrahydrofuryl triol, 2% of betaine, 18% of bioglycan gum, 1% of platinum powder, 1% of tocopherol succinate, 1% of malachite extract, 1% of ascorbyl tetraisopalmitate, 2% of aspartic acid, 0.5% of carnosine, 1% of scutellaria baicalensis root extract, 2% of phenethyl resorcinol, 2% of silybum marianum fruit extract, 1.5% of hypecol extract, 0.6% of avenin, 1% of lilium candidum flower extract, 2% of resveratrol, 121% of palmitoyl hexapeptide, 20.1% of ceramide, 1% of equisetum arvense extract, 0.5% of tranexamic acid, 0.05% of dipotassium glycyrrhizinate, 0.1% of chlorella vulgaris extract, 0.5% of lithospermum extract, 1% of leucine, 0.5% of jellyfish extract, 3% of tocopherol, and the balance of water.
The night cream of this example was prepared as follows:
s1, weighing the components according to the weight percentage, adding hydroxypropyl tetrahydrofuran triol, betaine, biogenic acid-1, tranexamic acid and water into a water phase reaction pot, uniformly mixing, heating to 90 ℃, stirring until the components are completely dissolved to obtain a water phase substance, and keeping the temperature for later use;
s2, adding jojoba oil, tocopherol succinate, resveratrol, ascorbyl tetraisopalmitate and radix scutellariae extract into an oil phase reaction pot, uniformly mixing, heating to 80 ℃, stirring until the components are completely dissolved to obtain an oil phase substance, and keeping the temperature for later use;
s3, transferring the water phase substance prepared in the step S1 into an emulsifying pot, slowly adding the oil phase substance prepared in the step S2 while stirring, continuously stirring for 60 minutes, then adding platinum powder and malachite extracts, dispersing uniformly, and cooling to 50 ℃;
s4, adding other materials into the mixture prepared in the step S3, continuously stirring for 30 minutes, and cooling to room temperature to obtain the material.
Example 3
A multi-effect antioxidant fine night cream comprises the following components in percentage by weight: 10% of jojoba oil, 20% of hydroxypropyl tetrahydrofuryl triol, 5% of betaine, 110% of bioglycan gum, 1% of platinum powder, 1% of tocopherol succinate, 1% of malachite extract, 1% of ascorbyl tetraisopalmitate, 2% of aspartic acid, 0.5% of carnosine, 1% of scutellaria baicalensis root extract, 2% of phenethyl resorcinol, 0.8% of silybum marianum fruit extract, 0.5% of hypecol extract, 0.6% of avenin, 2% of lilium candidum flower extract, 3% of resveratrol, 121% of palmitoyl hexapeptide, 20.1% of ceramide, 1% of equisetum arvense extract, 0.5% of tranexamic acid, 0.05% of dipotassium glycyrrhizinate, 0.1% of chlorella vulgaris extract, 0.5% of lithospermum extract, 1% of leucine, 0.5% of jellyfish extract, 3% of tocopherol, and the balance of water.
The night cream of this example was prepared as follows:
s1, weighing the components according to the weight percentage, adding hydroxypropyl tetrahydrofuran triol, betaine, biogenic acid-1, tranexamic acid and water into a water phase reaction pot, uniformly mixing, heating to 90 ℃, stirring until the components are completely dissolved to obtain a water phase substance, and keeping the temperature for later use;
s2, adding jojoba oil, tocopherol succinate, resveratrol, ascorbyl tetraisopalmitate and radix scutellariae extract into an oil phase reaction pot, uniformly mixing, heating to 80 ℃, stirring until the components are completely dissolved to obtain an oil phase substance, and keeping the temperature for later use;
s3, transferring the water phase substance prepared in the step S1 into an emulsifying pot, slowly adding the oil phase substance prepared in the step S2 while stirring, continuously stirring for 60 minutes, then adding platinum powder and malachite extracts, dispersing uniformly, and cooling to 50 ℃;
s4, adding other materials into the mixture prepared in the step S3, continuously stirring for 30 minutes, and cooling to room temperature to obtain the material.
Example 4
A multi-effect antioxidant fine night cream comprises the following components in percentage by weight: 10% of jojoba oil, 30% of hydroxypropyl tetrahydrofuryl triol, 5% of betaine, 110% of bioglycan gum, 1% of platinum powder, 1% of tocopherol succinate, 1% of malachite extract, 1% of ascorbyl tetraisopalmitate, 2% of aspartic acid, 0.5% of carnosine, 1% of scutellaria baicalensis root extract, 2% of phenethyl resorcinol, 0.8% of silybum marianum fruit extract, 0.5% of hypecol extract, 0.6% of avenin, 1% of lilium candidum flower extract, 3% of resveratrol, 121% of palmitoyl hexapeptide, 20.1% of ceramide, 1% of equisetum arvense extract, 0.5% of tranexamic acid, 0.05% of dipotassium glycyrrhizinate, 0.1% of chlorella vulgaris extract, 0.5% of lithospermum extract, 1% of leucine, 0.5% of jellyfish extract, 3% of tocopherol, and the balance of water.
The night cream of this example was prepared as follows:
s1, weighing the components according to the weight percentage, adding hydroxypropyl tetrahydrofuran triol, betaine, biogenic acid-1, tranexamic acid and water into a water phase reaction pot, uniformly mixing, heating to 90 ℃, stirring until the components are completely dissolved to obtain a water phase substance, and keeping the temperature for later use;
s2, adding jojoba oil, tocopherol succinate, resveratrol, ascorbyl tetraisopalmitate and radix scutellariae extract into an oil phase reaction pot, uniformly mixing, heating to 80 ℃, stirring until the components are completely dissolved to obtain an oil phase substance, and keeping the temperature for later use;
s3, transferring the water phase substance prepared in the step S1 into an emulsifying pot, slowly adding the oil phase substance prepared in the step S2 while stirring, continuously stirring for 60 minutes, then adding platinum powder and malachite extracts, dispersing uniformly, and cooling to 50 ℃;
s4, adding other materials into the mixture prepared in the step S3, continuously stirring for 30 minutes, and cooling to room temperature to obtain the material.
Example 5
A multi-effect antioxidant fine night cream comprises the following components in percentage by weight: 5% of jojoba oil, 25% of hydroxypropyl tetrahydrofuryl triol, 2% of betaine, 15% of bioglycan gum, 0.5% of platinum powder, 0.5% of tocopherol succinate, 1% of malachite extract, 1% of ascorbyl tetraisopalmitate, 5% of aspartic acid, 0.5% of carnosine, 1% of scutellaria root extract, 2% of phenethyl resorcinol, 0.8% of silybum marianum fruit extract, 0.5% of anise extract, 0.6% of oat peptide, 1% of lilium albo-marginatum extract, 2% of resveratrol, 121% of palmitoyl hexapeptide, 20.1% of ceramide, 1% of equisetum arvense extract, 0.5% of tranexamic acid, 0.05% of dipotassium glycyrrhizinate, 0.1% of chlorella extract, 0.5% of lithospermum extract, 1% of leucine, 0.5% of jellyfish extract, 3% of tocopherol, and the balance of water.
The night cream of this example was prepared as follows:
s1, weighing the components according to the weight percentage, adding hydroxypropyl tetrahydrofuran triol, betaine, biogenic acid-1, tranexamic acid and water into a water phase reaction pot, uniformly mixing, heating to 90 ℃, stirring until the components are completely dissolved to obtain a water phase substance, and keeping the temperature for later use;
s2, adding jojoba oil, tocopherol succinate, resveratrol, ascorbyl tetraisopalmitate and radix scutellariae extract into an oil phase reaction pot, uniformly mixing, heating to 80 ℃, stirring until the components are completely dissolved to obtain an oil phase substance, and keeping the temperature for later use;
s3, transferring the water phase substance prepared in the step S1 into an emulsifying pot, slowly adding the oil phase substance prepared in the step S2 while stirring, continuously stirring for 60 minutes, then adding platinum powder and malachite extracts, dispersing uniformly, and cooling to 50 ℃;
s4, adding other materials into the mixture prepared in the step S3, continuously stirring for 30 minutes, and cooling to room temperature to obtain the material.
To verify the effect of the night cream provided by the present invention, 50 female volunteers aged 18-50 years were invited, divided into 5 groups of 10 persons each, and the night creams of examples 1-5 were used, respectively. The participator applies night cream to be tested once a day in the evening and continuously uses the night cream for one month, and in the month, the participator does not use other night cream products in the evening. Subjects were screened for skin feel, moisturization, spreadability, stability of night creams. The scoring result is four grades of excellent (2.02.5), good (1.01.9), medium (0.40.9) and poor (00.3), and because the screening objects in the experiment are different, the scoring mode of the method has two modes of comprehensive scoring and single scoring. The comprehensive score means that the score is respectively graded from four angles of solubility, glossiness, coating and centrifugation, and the comprehensive score is the sum of all index scores and is 10 points full.
Table 2 comprehensive evaluation table of examples
Group of | Skin feel | Moisture retention | Spreadability | Stability of | Composite score |
Example 1 | 2.3 | 2.2 | 2.3 | 2.3 | 9.1 |
Example 2 | 1.8 | 1.8 | 2.0 | 2.2 | 7.8 |
Example 3 | 2.0 | 1.9 | 1.9 | 1.9 | 7.7 |
Example 4 | 1.9 | 1.5 | 1.9 | 2.0 | 7.3 |
Example 5 | 2.2 | 1.9 | 1.9 | 2.3 | 8.3 |
From the above test results, the night cream provided by the invention completely meets all indexes in the cosmetics health code (2007 edition) issued by the state, and the composition does not contain any toxic substance. And all participants considered that the skin feel, moisture retention, spreadability and stability of the night creams of examples 1-5 (especially example 1) achieved or even exceeded the results of the same type of commercial product.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (9)
1. The multi-effect antioxidant night cream is characterized by comprising the following components in percentage by weight: 5-15% of jojoba oil, 5-30% of hydroxypropyl tetrahydrofuran triol, 1-8% of betaine, 15-15% of bioglycan gum, 1-5% of resveratrol, 0.1-2% of platinum powder, 0.1-2% of tocopherol succinate, 0.1-2% of malachite extract, 0.1-2% of ascorbyl tetraisopalmitate, 0.5-5% of aspartic acid, 0.1-2% of carnosine, 0.2-2% of radix scutellariae extract, 0.1-2% of silybum marianum fruit extract, 0.1-2% of hypecol extract, 0.02-0.8% of oat peptide, 1-2% of lilium candidum flower extract, 0.01-0.5% of tranexamic acid and the balance of water.
2. The multi-effect antioxidant fine night cream as claimed in claim 1, further comprising 0.01-0.05% dipotassium glycyrrhizinate.
3. The multipurpose fine night cream according to claim 1, further comprising 0.1-2% of isobutyl palmitate.
4. The night cream as claimed in claim 1, further comprising 0.1-3% of phenylethyl resorcinol.
5. The fine multi-effect night cream according to claim 1, further comprising 0.01-0.5% palmitoyl hexapeptide-12, 0.01-0.5% ceramide 2, 0.1-3% tyrosine, and 0.1-3% tocopherol.
6. The night cream of claim 1, further comprising 0.01-2% of jellyfish extract.
7. The multi-effect fine night cream according to claim 6, wherein the jellyfish extract is prepared by the following steps: cleaning fresh jellyfish with clear water, cleaning with 1-2 times volume of soda water, cutting, adding 4-6 times volume of mixed solvent composed of anhydrous ethanol and n-hexane at a volume ratio of 8-10:1, heating to reflux, extracting for 3-6 hr, cooling, filtering, and concentrating the filtrate to obtain jellyfish extract.
8. The night cream as claimed in claim 1, further comprising 0.01-3% of herba Equiseti Arvinsis extract, 0.01-0.2% of Chlorella vulgaris extract, and 0.01-0.5% of Lithospermum erythrorhizon extract.
9. The method for preparing a fine night cream according to any one of claims 1 to 8, comprising the following steps:
s1, weighing the components according to the weight percentage, adding hydroxypropyl tetrahydrofuran triol, betaine, biogenic acid-1, tranexamic acid and water into a water phase reaction pot, uniformly mixing, heating to 80-90 ℃, stirring until the components are completely dissolved to obtain a water phase substance, and keeping the temperature for later use;
s2, adding jojoba oil, tocopherol succinate, resveratrol, ascorbyl tetraisopalmitate and radix scutellariae extract into an oil phase reaction pot, mixing uniformly, heating to 80-85 ℃, stirring until completely dissolved to obtain an oil phase substance, and keeping the temperature for later use;
s3, transferring the water phase substance prepared in the step S1 into an emulsifying pot, slowly adding the oil phase substance prepared in the step S2 while stirring, continuously stirring for 30-60 minutes, then adding platinum powder and malachite extracts, uniformly dispersing, and cooling to 40-50 ℃;
s4, adding other materials into the mixture prepared in the step S3, continuously stirring for 30-60 minutes, and cooling to room temperature to obtain the material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110624908.XA CN113440438A (en) | 2021-06-04 | 2021-06-04 | Multi-effect antioxidant fine night cream and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110624908.XA CN113440438A (en) | 2021-06-04 | 2021-06-04 | Multi-effect antioxidant fine night cream and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113440438A true CN113440438A (en) | 2021-09-28 |
Family
ID=77810757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110624908.XA Pending CN113440438A (en) | 2021-06-04 | 2021-06-04 | Multi-effect antioxidant fine night cream and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113440438A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116983217A (en) * | 2023-08-15 | 2023-11-03 | 广州环亚化妆品科技股份有限公司 | Composition containing phenethyl resorcinol, fennel extract and lactobacillus fermentation product and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434285A (en) * | 2015-12-31 | 2016-03-30 | 天津达仁堂京万红药业有限公司 | Moisturizing and nourishing facial cream and preparation method thereof |
CN108125892A (en) * | 2017-12-11 | 2018-06-08 | 百朗德生物化学(海门)有限公司 | A kind of marine organism moisture-retention anti-aging cosmetics composition |
CN108472202A (en) * | 2016-01-02 | 2018-08-31 | 莱雅公司 | Include the cosmetic composition of ceramide and cholesterol |
CN110169938A (en) * | 2019-06-18 | 2019-08-27 | 花安堂生物科技集团有限公司 | A kind of eye shadow suitable for sensitive skin |
-
2021
- 2021-06-04 CN CN202110624908.XA patent/CN113440438A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434285A (en) * | 2015-12-31 | 2016-03-30 | 天津达仁堂京万红药业有限公司 | Moisturizing and nourishing facial cream and preparation method thereof |
CN108472202A (en) * | 2016-01-02 | 2018-08-31 | 莱雅公司 | Include the cosmetic composition of ceramide and cholesterol |
CN108125892A (en) * | 2017-12-11 | 2018-06-08 | 百朗德生物化学(海门)有限公司 | A kind of marine organism moisture-retention anti-aging cosmetics composition |
CN110169938A (en) * | 2019-06-18 | 2019-08-27 | 花安堂生物科技集团有限公司 | A kind of eye shadow suitable for sensitive skin |
Non-Patent Citations (1)
Title |
---|
上海蕾俪生物科技有限公司: "《七典御延臻护夜霜》", 《国产普通化妆品备案信息》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116983217A (en) * | 2023-08-15 | 2023-11-03 | 广州环亚化妆品科技股份有限公司 | Composition containing phenethyl resorcinol, fennel extract and lactobacillus fermentation product and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102406581B (en) | Skin protecting composite with function of tightening skin | |
CN101444472B (en) | Skin care product | |
CN110638722A (en) | Anti-aging cosmetic and preparation method thereof | |
CN110787110A (en) | Composition with hair care effect and preparation method thereof | |
CN115531272B (en) | Antioxidant composition derived from alpine plants and preparation method and application thereof | |
CN105796457B (en) | A kind of scar anti-acne print lotion and preparation method thereof of dispelling rich in natural extract | |
CN106420527A (en) | Preparation method of moistening cream containing dendrobium officinale | |
CN116327674A (en) | Anti-wrinkle compact micro-nano essence emulsion and preparation method thereof | |
CN113440438A (en) | Multi-effect antioxidant fine night cream and preparation method thereof | |
CN110840757A (en) | Peony essence face cream and preparation process thereof | |
CN109431899A (en) | One kind 5 joins circle proferment pulp cosmetic and the preparation method and application thereof | |
CN104814916A (en) | Moisturizing essence and preparing method thereof | |
CN103340818B (en) | Massage tea oil | |
CN110403884A (en) | A kind of lipstick and preparation method thereof containing iron rod yam ingredient | |
CN107184543B (en) | Skin-care substrate with acne-inhibiting and acne-removing effects and preparation method and application thereof | |
CN105342966A (en) | Skin care moisturizer containing hirudo nipponia and preparation method of skin care moisturizer | |
CN115414289A (en) | Cordyceps flower cosmetics and preparation method thereof | |
CN108578296A (en) | A kind of delay aging drug extraction composition and its preparation and the application in cosmetics | |
CN108670912A (en) | A kind of preparation method of pure natural spice Essence | |
CN114748386A (en) | Preparation method and application of seven-white Chinese herbal medicine fermented raw juice with whitening effect | |
CN114642610A (en) | Moisturizing composition and preparation method and application thereof | |
CN112137939A (en) | Composition with functions of reducing fine lines and increasing skin elasticity, preparation method and application thereof | |
CN112842963A (en) | Saponin extract and preparation method and application thereof | |
CN111358719A (en) | Chinese herbal medicine lipstick with cheilitis preventing function and preparation method thereof | |
CN110897926A (en) | Antibacterial itching-relieving hair conditioner and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210928 |
|
RJ01 | Rejection of invention patent application after publication |